402 related articles for article (PubMed ID: 30156519)
41. Measles, mumps, rubella and varicella antibodies among international and domestic university students.
Dyda A; Broome A; Rawlinson W; Mahimbo A; Saha A; Kefalas B; Seale H; Macintyre CR; Zwar N; Gidding HF; Heywood AE
J Travel Med; 2024 Jan; 31(1):. PubMed ID: 38195239
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996.
dos Santos BA; Stralioto SM; Siqueira MM; Ranieri TS; Bercini M; Schermann MT; Wagner MB; Silveira TR
Rev Panam Salud Publica; 2006 Nov; 20(5):299-306. PubMed ID: 17316487
[TBL] [Abstract][Full Text] [Related]
43. Prospective Study of Live Attenuated Vaccines for Patients with Nephrotic Syndrome Receiving Immunosuppressive Agents.
Kamei K; Miyairi I; Ishikura K; Ogura M; Shoji K; Funaki T; Ito R; Arai K; Abe J; Kawai T; Onodera M; Ito S
J Pediatr; 2018 May; 196():217-222.e1. PubMed ID: 29499990
[TBL] [Abstract][Full Text] [Related]
44. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
Shinefield HR; Black S; Kuter BJ
J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
[TBL] [Abstract][Full Text] [Related]
45. Duration of immunity to measles, rubella and mumps during the first year of life.
Cilleruelo MJ; Fernández-García A; Villaverde S; Echevarría J; Marín MÁ; Sanz JC; López A; Royuela A; Antoran BR; de Ory F
Vaccine; 2019 Jul; 37(30):4164-4171. PubMed ID: 31151799
[TBL] [Abstract][Full Text] [Related]
46. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
47. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
Yoshida N; Tsumura N; Toyomasu K; Sagawa K
Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
[TBL] [Abstract][Full Text] [Related]
48. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age.
Yadav S; Thukral R; Chakarvarti A
Indian J Med Res; 2003 Nov; 118():183-6. PubMed ID: 14723482
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia.
Macartney K; Gidding HF; Trinh L; Wang H; Dey A; Hull B; Orr K; McRae J; Richmond P; Gold M; Crawford N; Kynaston JA; McIntyre P; Wood N;
JAMA Pediatr; 2017 Oct; 171(10):992-998. PubMed ID: 28806450
[TBL] [Abstract][Full Text] [Related]
50. A new combination vaccine for measles, mumps, rubella and varicella.
Zareba G
Drugs Today (Barc); 2006 May; 42(5):321-9. PubMed ID: 16801995
[TBL] [Abstract][Full Text] [Related]
51. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save?
Alp E; Cevahir F; Gökahmetoglu S; Demiraslan H; Doganay M
J Infect Public Health; 2012 Apr; 5(2):127-32. PubMed ID: 22541258
[TBL] [Abstract][Full Text] [Related]
52. Factors associated with incomplete vaccination and negative antibody test results for measles, mumps, and hepatitis A among children followed in the MINA-BRAZIL cohort.
Ferreira MS; Cardoso MA; Mazzucchetti L; Sabino EC; Avelino-Silva VI
Rev Inst Med Trop Sao Paulo; 2023; 65():e16. PubMed ID: 36921204
[TBL] [Abstract][Full Text] [Related]
53. Measles, mumps, and rubella antibody status and response to immunization in children after therapy for acute lymphoblastic leukemia.
Aytac S; Yalcin SS; Cetin M; Yetgin S; Gumruk F; Tuncer M; Yurdakok K; Gurgey A
Pediatr Hematol Oncol; 2010 Aug; 27(5):333-43. PubMed ID: 20469978
[TBL] [Abstract][Full Text] [Related]
54. Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
Habib MA; Prymula R; Carryn S; Esposito S; Henry O; Ravault S; Usonis V; Wysocki J; Gillard P; Povey M
Vaccine; 2021 Jun; 39(25):3445-3454. PubMed ID: 33736915
[TBL] [Abstract][Full Text] [Related]
55. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
56. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
[TBL] [Abstract][Full Text] [Related]
57. Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
Berry AA; Abu-Elyazeed R; Diaz-Perez C; Mufson MA; Harrison CJ; Leonardi M; Twiggs JD; Peltier C; Grogg S; Carbayo A; Shapiro S; Povey M; Baccarini C; Innis BL; Henry O
Hum Vaccin Immunother; 2017 Jul; 13(7):1516-1522. PubMed ID: 28481690
[TBL] [Abstract][Full Text] [Related]
58. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
[TBL] [Abstract][Full Text] [Related]
59. Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses.
Nicoara C; Zäch K; Trachsel D; Germann D; Matter L
Clin Diagn Lab Immunol; 1999 Nov; 6(6):868-71. PubMed ID: 10548578
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan.
Hatakeyama S; Moriya K; Itoyama S; Nukui Y; Uchida M; Shintani Y; Morisawa Y; Kimura S
Infect Control Hosp Epidemiol; 2004 Jul; 25(7):591-4. PubMed ID: 15301032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
